At the February 2015 ACIP meeting held last month, recommendations were made for meningococcal, influenza, and HPV vaccines. The updated recommendations for meningococcal and HPV vaccines were particularly important, as they each come with unique challenges.
You may have missed the recent webinars hosted by NFID, discussing how to overcome these challenges, but archived versions of the webinars are available online at www.nfid.org/webinars:
The Role of New Serogroup B Vaccines in Preventing Meningitis Outbreaks: NFID experts, Carol J. Baker, MD, Lorry G. Rubin, MD, and William Schaffner, MD, discuss unique challenges of meningococcal disease, new ACIP recommendations for serogroup B vaccine use, and considerations for future recommendations.
Five Key Steps to Improve HPV Vaccination Rates in Your Practice: Joseph A. Bocchini, Jr., MD and Noel T. Brewer, PhD discuss HPV vaccination barriers and opportunities and will present five key steps that healthcare professionals (HCPs) can take to improve HPV vaccination rates in their practices, based on the NFID Call to Action, HPV Vaccination as a Public Health Priority.
Related Posts
There’s Nothing New About Applying a ‘Gold Standard’ to Vaccine Trials
How vaccine clinical trials work—and the true “gold standard” for safety, effectiveness, and ethics
News Round-Up: Public Health in Flux
News and expert insights on public health policy, outbreak response, and evolving risks across the US and globally
The Hidden Cost of a Sick Week: Flu’s Economic Impact
Flu disrupts daily life in ways that can linger long after symptoms fade. And nationally, those disruptions add up to a staggering economic impact.